These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

558 related articles for article (PubMed ID: 16964339)

  • 1. Is there a benefit of 131 I-MIBG therapy in the treatment of children with stage 4 neuroblastoma? A retrospective evaluation of The German Neuroblastoma Trial NB97 and implications for The German Neuroblastoma Trial NB2004.
    Schmidt M; Simon T; Hero B; Eschner W; Dietlein M; Sudbrock F; Bongartz R; Berthold F; Schicha H
    Nuklearmedizin; 2006; 45(4):145-51; quiz N39-40. PubMed ID: 16964339
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intensified external-beam radiation therapy improves the outcome of stage 4 neuroblastoma in children > 1 year with residual local disease.
    Simon T; Hero B; Bongartz R; Schmidt M; Müller RP; Berthold F
    Strahlenther Onkol; 2006 Jul; 182(7):389-94. PubMed ID: 16826357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase II study on the effect of disease sites, age, and prior therapy on response to iodine-131-metaiodobenzylguanidine therapy in refractory neuroblastoma.
    Matthay KK; Yanik G; Messina J; Quach A; Huberty J; Cheng SC; Veatch J; Goldsby R; Brophy P; Kersun LS; Hawkins RA; Maris JM
    J Clin Oncol; 2007 Mar; 25(9):1054-60. PubMed ID: 17369569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prognostic impact of functional imaging with (123)I-mIBG in patients with stage 4 neuroblastoma >1 year of age on a high-risk treatment protocol: results of the German Neuroblastoma Trial NB97.
    Schmidt M; Simon T; Hero B; Schicha H; Berthold F
    Eur J Cancer; 2008 Jul; 44(11):1552-8. PubMed ID: 18424129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of advanced neuroblastoma: feasibility and therapeutic potential of a novel approach combining 131-I-MIBG and multiple drug chemotherapy.
    Mastrangelo S; Tornesello A; Diociaiuti L; Pession A; Prete A; Rufini V; Troncone L; Mastrangelo R
    Br J Cancer; 2001 Feb; 84(4):460-4. PubMed ID: 11207038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Iodine-131-metaiodobenzylguanidine as initial induction therapy in stage 4 neuroblastoma patients over 1 year of age.
    de Kraker J; Hoefnagel KA; Verschuur AC; van Eck B; van Santen HM; Caron HN
    Eur J Cancer; 2008 Mar; 44(4):551-6. PubMed ID: 18267358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase I dose escalation of iodine-131-metaiodobenzylguanidine with myeloablative chemotherapy and autologous stem-cell transplantation in refractory neuroblastoma: a new approaches to Neuroblastoma Therapy Consortium Study.
    Matthay KK; Tan JC; Villablanca JG; Yanik GA; Veatch J; Franc B; Twomey E; Horn B; Reynolds CP; Groshen S; Seeger RC; Maris JM
    J Clin Oncol; 2006 Jan; 24(3):500-6. PubMed ID: 16421427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation of tumor and whole-body dosimetry with tumor response and toxicity in refractory neuroblastoma treated with (131)I-MIBG.
    Matthay KK; Panina C; Huberty J; Price D; Glidden DV; Tang HR; Hawkins RA; Veatch J; Hasegawa B
    J Nucl Med; 2001 Nov; 42(11):1713-21. PubMed ID: 11696644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The treatment of neuroblastoma with [131I]MIBG at diagnosis.
    Troncone L; Rufini V; Luzi S; Mastrangelo R; Riccardi R
    Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):65-8. PubMed ID: 9002753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Place of meta-[131I]iodobenzylguanidine in the treatment of neuroblastoma: the Genoa experience.
    Garaventa A; Pianca C; Conte M; Nigro M; De Bernardi B; Claudiani F; Stimamiglio P; Bertolazzi L; Cabria M; Villavecchia GP
    Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):58-60. PubMed ID: 9002751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Favorable prognosis for patients 12 to 18 months of age with stage 4 nonamplified MYCN neuroblastoma: a Children's Cancer Group Study.
    Schmidt ML; Lal A; Seeger RC; Maris JM; Shimada H; O'Leary M; Gerbing RB; Matthay KK
    J Clin Oncol; 2005 Sep; 23(27):6474-80. PubMed ID: 16116154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Review of image defined risk factors in localized neuroblastoma patients: Results of the GPOH NB97 trial.
    Simon T; Hero B; Benz-Bohm G; von Schweinitz D; Berthold F
    Pediatr Blood Cancer; 2008 May; 50(5):965-9. PubMed ID: 17914735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 131I-metaiodobenzylguanidine (131I-MIBG) therapy for residual neuroblastoma: a mono-institutional experience with 43 patients.
    Garaventa A; Bellagamba O; Lo Piccolo MS; Milanaccio C; Lanino E; Bertolazzi L; Villavecchia GP; Cabria M; Scopinaro G; Claudiani F; De Bernardi B
    Br J Cancer; 1999 Dec; 81(8):1378-84. PubMed ID: 10604736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Localised and unresectable neuroblastoma in infants: excellent outcome with primary chemotherapy. Neuroblastoma Study Group, Société Française d'Oncologie Pédiatrique.
    Rubie H; Plantaz D; Coze C; Michon J; Frappaz D; Baranzelli MC; Chastagner P; Peyroulet MC; Hartmann O;
    Med Pediatr Oncol; 2001 Jan; 36(1):247-50. PubMed ID: 11464897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pretreatment with [131I] metaiodobenzylguanidine and surgical resection of advanced neuroblastoma.
    van Hasselt EJ; Heij HA; de Kraker J; Vos A; Voûte PA
    Eur J Pediatr Surg; 1996 Jun; 6(3):155-8. PubMed ID: 8817208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [131I meta-iodobenzylguanidine in combination with hyperbaric oxygen therapy in the treatment of prognostically high-risk forms of neuroblastoma].
    Stanková J; Kavan P; Krízová H; Hermanská E; Dosel P; Sázel M
    Cas Lek Cesk; 2001 Jan; 140(1):13-7. PubMed ID: 11242978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tandem high-dose chemotherapy and autologous stem cell rescue in patients over 1 year of age with stage 4 neuroblastoma.
    Sung KW; Lee SH; Yoo KH; Jung HL; Cho EJ; Koo HH; Lee SK; Kim J; Lim DH; Suh YL; Kim DW
    Bone Marrow Transplant; 2007 Jul; 40(1):37-45. PubMed ID: 17468771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and efficacy of tandem 131I-metaiodobenzylguanidine infusions in relapsed/refractory neuroblastoma.
    Johnson K; McGlynn B; Saggio J; Baniewicz D; Zhuang H; Maris JM; Mosse YP
    Pediatr Blood Cancer; 2011 Dec; 57(7):1124-9. PubMed ID: 21495159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined use of chemotherapy and 131I-metaiodobenzylguanidine in the treatment of advanced-stage neuroblastoma.
    Sari O; Uğur O; Emir S; Akyüz C
    Turk J Pediatr; 2001; 43(1):29-33. PubMed ID: 11297155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [131I]MIBG as a first line treatment in advanced neuroblastoma.
    Hoefnagel CA; De Kraker J; Valdés Olmos RA; Voûte PA
    Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):61-4. PubMed ID: 9002752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.